HilleVax (HLVX) Income Statement (2022 - 2025)
Income Statement report data from Jun 30, 2022 to Jun 30, 2025 for HilleVax (HLVX).
Reported currency: USD
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||
Research And Development | 1.33M (-32.83%) | 1.98M (-63.54%) | 5.43M (-73.08%) | 20M (-24.17%) | 27M (-35.59%) | 41M (+24.17%) | 33M (+21.79%) | 27M (+19.00%) | 23M (-0.91%) | 23M (+31.89%) | 18M (+31.83%) | 13M (+50.85%) | 8.83M |
Selling General And Administrative | 5.66M (+0.71%) | 5.62M (-5.55%) | 5.95M (-4.34%) | 6.22M (-23.49%) | 8.13M (-4.24%) | 8.49M (+20.77%) | 7.03M (+6.52%) | 6.60M (-8.71%) | 7.23M (+24.66%) | 5.80M (+4.69%) | 5.54M (+20.96%) | 4.58M (+15.08%) | 3.98M |
Operating Expenses | 6.99M (-8.03%) | 7.60M (-78.98%) | 36M (+37.04%) | 26M (-38.59%) | 43M (-13.73%) | 50M (+23.60%) | 40M (+18.81%) | 34M (+12.36%) | 30M (+4.21%) | 29M (+25.37%) | 23M (+29.12%) | 18M (+39.66%) | 13M |
Operating Income | |||||||||||||
Operating Income | -6.98M (-8.16%) | -7.60M (-78.98%) | -36.15M (+37.04%) | -26.38M (-38.59%) | -42.96M (-13.73%) | -49.80M (+23.60%) | -40.29M (+18.81%) | -33.91M (+12.36%) | -30.18M (+4.21%) | -28.96M (+25.37%) | -23.10M (+29.12%) | -17.89M (+39.66%) | -12.81M |
EBITDA | -6.74M (-8.30%) | -7.35M (-32.57%) | -10.90M (-58.68%) | -26.38M (-23.00%) | -34.26M (-30.56%) | -49.34M (+23.78%) | -39.86M (+18.74%) | -33.57M (+11.60%) | -30.08M (+3.87%) | -28.96M (+27.07%) | -22.79M (+27.39%) | -17.89M (+39.66%) | -12.81M |
Other Income / Expenses | |||||||||||||
Interest Income | 750K (-3.85%) | 780K (-51.25%) | 1.60M (+18.52%) | 1.35M (-20.59%) | 1.70M (-29.17%) | 2.40M (-19.73%) | 2.99M (+76.92%) | 1.69M (-31.02%) | 2.45M (-4.67%) | 2.57M (+15.77%) | 2.22M (+68.18%) | 1.32M (+300.00%) | 330K |
Interest Expense | - | - | - | -1.85M (+150.00%) | -740.00K (+1.37%) | -730.00K (0.00%) | -730.00K (+1.39%) | -720.00K (+44.00%) | -500.00K (+11.11%) | -450.00K (+73.08%) | -260.00K (+30.00%) | -200.00K (-77.53%) | -890.00K |
Net Interest Income | 750K (-3.85%) | 780K (-51.25%) | 1.60M (-50.16%) | 3.21M (+31.56%) | 2.44M (-22.04%) | 3.13M (-15.86%) | 3.72M (+54.36%) | 2.41M (-18.31%) | 2.95M (-2.32%) | 3.02M (+21.77%) | 2.48M (+63.16%) | 1.52M (+24.59%) | 1.22M |
Other Non Operating Income | 970K (+25.97%) | 770K (+28.33%) | 600K (-43.40%) | 1.06M (-20.90%) | 1.34M (+3.88%) | 1.29M (+20.56%) | 1.07M (-4.46%) | 1.12M (+239.39%) | 330K | -50.00K (0.00%) | -50.00K (+150.00%) | -20.00K (-99.95%) | -40.57M |
Net Income | |||||||||||||
Income Before Tax | -5.27M (-13.04%) | -6.06M (-82.15%) | -33.95M (+31.49%) | -25.82M (-36.51%) | -40.67M (-13.15%) | -46.83M (+26.70%) | -36.96M (+16.19%) | -31.81M (+14.01%) | -27.90M (+3.76%) | -26.89M (+26.90%) | -21.19M (+26.13%) | -16.80M (-68.85%) | -53.93M |
Net Income From Continuing Operations | -5.27M (-13.04%) | -6.06M (-82.15%) | -33.95M (+31.49%) | -25.82M (-36.51%) | -40.67M (-13.15%) | -46.83M (+26.70%) | -36.96M (+16.19%) | -31.81M (+14.01%) | -27.90M (+3.76%) | -26.89M (+26.90%) | -21.19M (+26.13%) | -16.80M (-68.85%) | -53.93M |
Net Income | -5.27M (-13.04%) | -6.06M (-82.15%) | -33.95M (+31.49%) | -25.82M (-36.51%) | -40.67M (-13.15%) | -46.83M (+26.70%) | -36.96M (+16.19%) | -31.81M (+14.01%) | -27.90M (+3.76%) | -26.89M (+26.90%) | -21.19M (+26.13%) | -16.80M (-68.85%) | -53.93M |